PT  - JOURNAL ARTICLE
AU  - Monira Parveen
AU  - Mahmuda Yeasmin
AU  - Md. Maruf Ahmed Molla
TI  - Antimicrobial Resistance, Evidences on Irrational Anti-microbial Prescribing and Consumption during COVID-19 Pandemic and Possible Mitigation Strategies: A Bangladesh Perspective
AID  - 10.1101/2020.10.09.20210377
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.09.20210377
4099  - http://medrxiv.org/content/early/2020/10/13/2020.10.09.20210377.short
4100  - http://medrxiv.org/content/early/2020/10/13/2020.10.09.20210377.full
AB  - There are evidences that show increased antimicrobial consumption among COVID-19 patients. This has increased the burden on worsening situation of antimicrobial resistance (AMR) throughout the world. Bangladesh, one of the countries with highest numbers of COVID-19 cases, without effective regulation of antimicrobial prescription may suffer in future with study results showing a significant proportion of participants taking antimicrobial without proper indication and prescription from physicians. Suggested mitigation strategies include – strict regulation of over the counter (OTC) antimicrobial prescription, testing biochemical marker such as procalcitonin prior to initiation of antimicrobial therapy, introduction of color coded and tightly sealed bottled antimicrobial drugs, massive campaigning on social media, effective utilization of telemedicine and finally, raising awareness among physicians and patients regarding judicial use of antimicrobial.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received from any agency/organizationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB clearance was obtained from Dhaka Dental College ethical review board (DDC/2020/42)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data regarding participants are available and could be provided on request